| Primary |
| Product Used For Unknown Indication |
61.9% |
| Delirium |
9.5% |
| Alcohol Use |
4.8% |
| Anxiety Disorder |
4.8% |
| Drug Dependence |
4.8% |
| Drug Use For Unknown Indication |
4.8% |
| Infection |
4.8% |
| Sleep Disorder |
4.8% |
|
| Suicide Attempt |
40.0% |
| Ischaemic Stroke |
20.0% |
| Visual Acuity Reduced |
20.0% |
| Weight Decreased |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
37.4% |
| Drug Use For Unknown Indication |
29.7% |
| Bipolar I Disorder |
6.2% |
| Anxiety |
5.2% |
| Depression |
3.5% |
| Hypertension |
3.0% |
| Type 2 Diabetes Mellitus |
2.5% |
| Pain |
2.4% |
| Endocarditis |
1.3% |
| Psychotic Disorder |
1.0% |
| Breast Cancer |
0.9% |
| Colon Cancer |
0.9% |
| Ill-defined Disorder |
0.8% |
| Dyslipidaemia |
0.8% |
| Cardiac Failure |
0.8% |
| Hiv Infection |
0.8% |
| Insomnia |
0.7% |
| Prophylaxis |
0.7% |
| Suicide Attempt |
0.7% |
| Myocardial Ischaemia |
0.7% |
|
| Fall |
8.0% |
| Somnolence |
8.0% |
| Vomiting |
8.0% |
| Rhabdomyolysis |
7.5% |
| Hypertriglyceridaemia |
7.0% |
| Toxic Skin Eruption |
6.0% |
| Pancreatic Carcinoma |
5.0% |
| Vascular Purpura |
5.0% |
| Orthostatic Hypotension |
4.5% |
| Pulmonary Embolism |
4.5% |
| Respiratory Distress |
4.5% |
| Suicide Attempt |
4.5% |
| Intra-uterine Death |
4.0% |
| Cytolytic Hepatitis |
3.5% |
| Interstitial Lung Disease |
3.5% |
| Overdose |
3.5% |
| Pyrexia |
3.5% |
| Agranulocytosis |
3.0% |
| Death |
3.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.8% |
| Drug Use For Unknown Indication |
20.9% |
| Depression |
6.6% |
| Hypertension |
6.3% |
| Anxiety |
6.2% |
| Pain |
4.9% |
| Prophylaxis |
4.8% |
| Hiv Infection |
3.9% |
| Insomnia |
2.4% |
| Rheumatoid Arthritis |
2.2% |
| Hepatitis C |
2.0% |
| Multiple Myeloma |
1.6% |
| Parkinson's Disease |
1.6% |
| Breast Cancer |
1.4% |
| Osteoporosis |
1.4% |
| Nausea |
1.4% |
| Constipation |
1.2% |
| Dyslipidaemia |
1.2% |
| Type 2 Diabetes Mellitus |
1.1% |
| Diabetes Mellitus |
1.1% |
|
| Vomiting |
12.2% |
| Thrombocytopenia |
11.5% |
| Renal Failure Acute |
10.6% |
| Weight Decreased |
6.3% |
| Renal Failure |
5.4% |
| Pyrexia |
4.6% |
| Neutropenia |
4.5% |
| Rhabdomyolysis |
4.3% |
| Tremor |
4.1% |
| Pulmonary Embolism |
3.9% |
| Somnolence |
3.9% |
| Septic Shock |
3.5% |
| General Physical Health Deterioration |
3.3% |
| Pruritus |
3.3% |
| Suicide Attempt |
3.3% |
| Hyponatraemia |
3.2% |
| Myocardial Infarction |
3.2% |
| Overdose |
3.0% |
| Tachycardia |
3.0% |
| Toxic Skin Eruption |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
36.8% |
| Product Used For Unknown Indication |
15.8% |
| Anxiety |
6.6% |
| Psychotic Disorder |
5.3% |
| Hypertension |
3.9% |
| Pain |
3.9% |
| Abnormal Behaviour |
2.6% |
| Asthma |
2.6% |
| Atrial Fibrillation |
2.6% |
| Depression |
2.6% |
| Insomnia |
2.6% |
| Sleep Disorder |
2.6% |
| Type 2 Diabetes Mellitus |
2.6% |
| Ankylosing Spondylitis |
1.3% |
| Contraception |
1.3% |
| Dementia |
1.3% |
| Essential Hypertension |
1.3% |
| Extrapyramidal Disorder |
1.3% |
| Hallucination |
1.3% |
| Hypersensitivity |
1.3% |
|
| Somnolence |
19.0% |
| Orthostatic Hypotension |
14.3% |
| General Physical Health Deterioration |
9.5% |
| Psychomotor Retardation |
9.5% |
| Thoracic Vertebral Fracture |
9.5% |
| Fall |
4.8% |
| Femoral Neck Fracture |
4.8% |
| Hyponatraemia |
4.8% |
| Labelled Drug-drug Interaction Medication Error |
4.8% |
| Multiple Drug Overdose Intentional |
4.8% |
| Pneumonia Aspiration |
4.8% |
| Respiratory Distress |
4.8% |
| Unintended Pregnancy |
4.8% |
|
